Clinical trial

A Repeat Dose Positron Emission Tomography Study With GSK1144814

NCT01209039

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-07-01

PhasePHASE1

Study timeline

Study start (actual)2009-07-01Date precision: day

Registry last updated2017-06-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

GSK1144814DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01209039 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.